{"Title": "We can compare the relative efficacy of multiple sclerosis medications by examining the results of independent clinical trials: No", "Year": 2015, "Source": "Mult. Scler. J.", "Volume": "21", "Issue": 1, "Art.No": null, "PageStart": 37, "PageEnd": 38, "CitedBy": 2, "DOI": "10.1177/1352458514559866", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922912661&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Clinical Trials as Topic", "Humans", "Multiple Sclerosis, Relapsing-Remitting", "Outcome Assessment (Health Care)"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84922912661", "SubjectAreas": [["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"7003671038": {"Name": "Ciccarelli O.", "AuthorID": "7003671038", "AffiliationID": "60019953", "AffiliationName": "Queen Square MS Centre, UCL Institute of Neurology"}, "57212501583": {"Name": "Chataway J.", "AuthorID": "57212501583", "AffiliationID": "60022148, 60024544", "AffiliationName": "NIHR UCL, UCLH Biomedical Research Centre (BRC)"}}}